Long-term Effect and Prognostic Factors of 582 Nasopharyngeal Carcinoma Patients Treated with Intensity Modulated Radiotherapy
M. Feng,J. Lang,Z. Fan,J. Li,T. Li,H. Wen,J. Wang,W. Wang
DOI: https://doi.org/10.1016/j.ijrobp.2011.06.1691
2011-01-01
Abstract:To evaluate the long term effect of 582 nasopharyngeal carcinoma (NPC) patients treated with intensity modulated radiotherapy (IMRT) and to analyze the prognostic factors. Five hundred eighty-two NPC patients treated with IMRT in Si Chuan Cancer Hospital from Jan.2001 to Dec.2004 were reviewed retrospectively. According to 2002 UICC staging system, 36 patients had Stage I, 144 Stage II, 224 Stage III, and 178 Stage IV lesions. One hundred ninety-eight patients only received radical IMRT, while 384 patients received IMRT combined with chemotherapy. The prescription dose was delivered as follows: gross target volume (GTVnx) received 68 – 76 Gy in 30 – 33 fractions, positive neck lymph nodes (GTVln-R/L) received 60 – 70 Gy in 30 – 33 fractions, high-risk clinical target volume (CTV1) received 60 – 66 Gy, low-risk clinical target volume (CTV2) received 54 – 60 Gy, clinical target volume of cervical lymph node regions (CTVln) received 50 – 55 Gy. The Kaplan-Meier method was used to calculate the local-regional control rate (LC), regional control rate (RC), distant metastasis-free survival rate (DMSF), disease-free survival rate (DFS), disease-specific survival rate (DSS) and overall survival rate (OS). Log-rank test was used for the univariate analysis, and Cox proportional hazard model for the multivariate analysis. Acute and late toxicities were graded according to the RTOG radiation morbidity scoring criteria. The median follow-up interval was 66.4 months. There were 29, 13 and 117 patients who had developed local, regional and distant recurrence respectively. The 133 patients died. The 5-year LC, RC, DMFS, DFS, DSS and OS was 89.8%, 95.2%, 74.1%, 69.6%, 83.2% and 77.1%. The incidence of Grade 3 acute and late toxicity was 38.3% and 4.24%. Xerostomia was the most common late toxicity. No patient had occurred Grade 4 toxicities. The 5-year DMFS of IMRT and IMRT combined with chemotherapy was 73.2% and 78.0%, the OS of them was 75.8% and 79.2%. The 5-year LC of GTVnx 30 cm3 (93.6% vs. 80.4%, p < 0.05). The 5-year RC of GTVln 10 cm3 (96.3 vs. 85.0%, p < 0.05). Univariate analysis revealed that gender, T/N-Stage, clinical stage, radiotherapy interruption, HGB, biological dose of GTVnx, lose weight and chemotherapy was the significant prognostic factor for the OS. Meanwhile, multivariate analysis showed that clinical stage, N-Stage, chemotherapy, radiotherapy interruption, the volume of GTVnx, age, HGB, gender, and loss weight was the independent prognostic factors for the OS in order. IMRT technique has dramatically improved the clinical effect of nasopharyngeal carcinoma, especially for the LC and RC. The late toxicities were acceptable. Distant metastasis was the main cause of failure.